294 related articles for article (PubMed ID: 27737655)
1. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats.
Fernández-Varón E; Cárceles-García C; Serrano-Rodríguez JM; Cárceles-Rodríguez CM
BMC Vet Res; 2016 Oct; 12(1):232. PubMed ID: 27737655
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
[TBL] [Abstract][Full Text] [Related]
4. Milk and serum concentration of ceftiofur following intramammary infusion in goats.
Garrett EF; Dirikolu L; Grover GS
J Vet Pharmacol Ther; 2015 Dec; 38(6):569-74. PubMed ID: 25707268
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and milk penetration of difloxacin after a long-acting formulation for subcutaneous administration to lactating goats.
Marín P; Escudero E; Fernández-Varón E; Ramírez MJ; Cárceles CM
J Dairy Sci; 2010 Jul; 93(7):3056-64. PubMed ID: 20630222
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats.
Lorenzutti AM; Litterio NJ; Himelfarb MA; Zarazaga MDP; San Andrés MI; De Lucas JJ
J Vet Pharmacol Ther; 2017 Dec; 40(6):629-640. PubMed ID: 28470723
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Potter T; Pelligand L; Toutain PL
J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefonicid in lactating goats after intravenous, intramuscular and subcutaneous administration, and after a long-acting formulation for subcutaneous administration.
Badillo E; Escudero E; Hernandis V; Galecio JS; Marín P
J Vet Pharmacol Ther; 2020 Jan; 43(1):50-56. PubMed ID: 31724779
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats.
Sidhu PK; Landoni MF; Aliabadi FS; Lees P
Vet J; 2010 May; 184(2):219-29. PubMed ID: 19299172
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of amoxicillin against Mannheimia haemolytica and Pasteurella multocida and pharmacokinetic/pharmacodynamic (PK/PD) correlation in sheep.
Delis GA; Koutsoviti-Papadopoulou M; Siarkou VI; Kounenis G; Batzias GC
Res Vet Sci; 2010 Dec; 89(3):418-25. PubMed ID: 20363488
[TBL] [Abstract][Full Text] [Related]
12. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
Lees P; Illambas J; Pelligand L; Toutain PL
Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility patterns of respiratory tract pathogens from sheep and goats.
Berge AC; Sischo WM; Craigmill AL
J Am Vet Med Assoc; 2006 Oct; 229(8):1279-81. PubMed ID: 17042733
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ceftiofur crystalline free acid after single subcutaneous administration in lactating and nonlactating domestic goats (Capra aegagrus hircus).
Doré E; Angelos JA; Rowe JD; Carlson JL; Wetzlich SE; Kieu HT; Tell LA
J Vet Pharmacol Ther; 2011 Feb; 34(1):25-30. PubMed ID: 21219340
[TBL] [Abstract][Full Text] [Related]
16. PK/PD Analysis of Marbofloxacin by Monte Carlo Simulation against
Fernández-Varón E; García-Romero E; Serrano-Rodríguez JM; Cárceles CM; García-Galán A; Cárceles-García C; Fernández R; Muñoz C; de la Fe C
Animals (Basel); 2021 Apr; 11(4):. PubMed ID: 33921496
[TBL] [Abstract][Full Text] [Related]
17. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
Portis E; Lindeman C; Johansen L; Stoltman G
J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
[TBL] [Abstract][Full Text] [Related]
18. Distribution of ceftiofur into Mannheimia haemolytica-infected tissue chambers and lung after subcutaneous administration of ceftiofur crystalline free acid sterile suspension.
Washburn K; Johnson R; Clarke C; Anderson K
J Vet Pharmacol Ther; 2010 Apr; 33(2):141-6. PubMed ID: 20444038
[TBL] [Abstract][Full Text] [Related]
19. PK-PD integration and modeling of marbofloxacin in sheep.
Sidhu PK; Landoni MF; Aliabadi FS; Lees P
Res Vet Sci; 2010 Feb; 88(1):134-41. PubMed ID: 19523661
[TBL] [Abstract][Full Text] [Related]
20. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
